Comment from Wags to Whiskers Veterinary Clinic
AnonymousOpposeIndividual
Summary: A pet owner argues against the restriction of Methimazole for in-clinic use, stating that it causes treatment delays and reduces patient compliance. They highlight that liquid and transdermal forms are easier for owners to administer than tablets and that the new regulations do not serve the best interests of cats.
This is regards to Methimazole and the new regulations that this medication cannot be dispensed to a veterinary clinic for in clinic usage. Methimazole is an important medication used to treat hypothyroidism in cats. This is a common ailment in again cats that can cause severe weight loss and if left untreated can cause cardiac issues. I personally have had 2 cats this with disease/ailment ( 1 that I am currently treating). Restricting this medication is causing delays in starting a pet's treatment. If medication cannot be started right away, some owners refuse to return to pick up medication. Secondly, owners forget to call in when medication is getting low, so then there is a lapse in treatment until medication can be obtained from the pharmacy. Plus, if an owner has to go to a local pharmacy to pick up medication, this is now another errand they need to run, which can be difficult for an elderly client or a client with young children. Lastly, while tablets are available, pilling a cat can be most difficult. Compliance is much easier with liquid medications and transdermal medications. Some pharmacies, need to make up these preparations once they receive the order, adding to the delay of receiving the medication for the pet. This decision was not made in the best interest of of feline companions.